Efficacy

Median Event Free Survival* was significantly longer with MYLOTARG™ + chemotherapy vs chemotherapy alone1

ALFA-0701 study

Figure adapted from MYLOTARG™ Summary of Product Characteristics

* Defined as the time from randomisation to the date of assessment of the response (if CR or CRp had not been achieved), relapse or death.

CHEMO, chemotherapy; CI, confidence interval; CR, complete remission; CRp, complete remission with incomplete platelet recovery; EFS, event-free survival; HR, hazard rarios; mo, months; MYLO, MYLOTARG™

Reference

  1. MYLOTARG™ Summary of Marketing Product Characteristics.

PP-MYL-GBR-0087. December 2019